Oragenics
OGEN
14 hedge funds and large institutions have $4.58M invested in Oragenics in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
27% more funds holding
Funds holding: 11 → 14 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
44% less capital invested
Capital invested by funds: $8.16M → $4.58M (-$3.58M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$12.6K |
| 2 |
VF
Virtu Financial
New York
|
+$12.6K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.29K |
| 4 |
Renaissance Technologies
New York
|
+$6.29K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.29K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$19K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$6.29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TS
1
Third Security
Radford,
Virginia
| $3.64M | – | – | – |
|
|
MP
2
MSD Partners
New York
| $405K | – | – | – |
|
3
Fidelity Investments
Boston,
Massachusetts
| $391K | – | – | – |
|
4
Bank of New York Mellon
New York
| $47K | – | – | – |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| $22K | -$6.29K | -1 | -17% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $21K | – | – | – |
|
|
VF
7
Virtu Financial
New York
| $13K | +$12.6K | +2 | +200% |
|
|
8
Citadel Advisors
Miami,
Florida
| $10K | +$12.6K | +2 | New |
|
|
IA
9
IFP Advisors
Tampa,
Florida
| $7K | – | – | – |
|
10
Northern Trust
Chicago,
Illinois
| $7K | – | – | – |
|
|
GC
11
Guggenheim Capital
Chicago,
Illinois
| $4K | – | – | – |
|
|
12
UBS Group
Zurich,
Switzerland
| $4K | +$6.29K | +1 | New |
|
|
HWM
13
Holloway Wealth Management
Gainesville,
Florida
| $3K | – | – | – |
|
|
14
Renaissance Technologies
New York
| $3K | +$6.29K | +1 | New |
|
15
BlackRock
New York
| $2K | – | – | – |
|
|
16
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$6.29K | +1 | New |
|
|
BCM
17
Bridgeway Capital Management
Houston,
Texas
| – | -$19K | -3 | Closed |
|
OGEN Hedge Fund Activity: Q4 2017 in Review
14 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2017, worth a combined $4.58M — down 44% from $8.16M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OGEN positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $12.6K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $19K sold.
- 14 institutional investors held Oragenics (OGEN) as of Q4 2017, up from 11 in Q3 2017.
- Funds reported $4.58M of Oragenics stock for Q4 2017, down 44% quarter-over-quarter.
- 4 funds opened new Oragenics positions in Q4 2017 and 1 closed out, a net change of +3 holders.
- The largest Oragenics buyer in Q4 2017 was Citadel Advisors, an estimated $12.6K added.
- The largest Oragenics seller in Q4 2017 was Bridgeway Capital Management, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2017.